Abstract:Currently there is no reliable nomogram to predict the overall survival (OS) for patients with esophageal squamous cancer (ESCC) after chemoradiation therapy followed by surgery. The purpose of this study is to develop the above nomogram through the correlation of pretreatment clinical features that are commonly indicated for prognosis. We searched through Surveillance, Epidemiology, and End Results (SEER) database. A criterion for the search is listed as follows: (1) patients diagnosed with pathologically proved ESCC; (2) patients diagnosed in 2010-2014(AJCC 2010 7th version); (3) patients with T1-4N0-3M0 disease; (4) patients underwent chemoradiation therapy followed by surgery. Age, ethnicity, sex, Primary Site of the tumor, T stage, N stage were recorded as clinical predictors. These predictors were used in multivariable logistic regression analysis based nomograms to estimate the probabilities of OS. The predictive accuracy and discriminative ability of the nomogram were determined by concordance index (C-index) and calibration curve. Analyses were performed with open-source statistical software R (version 3.2.1). There were 5,508 patients with ESCC diagnosed in 2010-2014, 326 patients were identified. A total of 41% of patients were male. A total of 62% were aged 50 to 70.72% and were in the white race. Proportion of the patients diagnosed in T1, T2, T3, and T4 were 15%, 18%, 63%, and 4%; 92% of the patients were in N0-1 stage; 88.3% of the tumor were located in middle and lower third of esophagus; only 4% had overlapping lesion of esophagus. The 3-year and 4-year OS for the entire cohort of the patients were 53%, 47% with the median survival time of 45 months. Median survival of male and female patients were 38 months vs. 54 months (p=0.024); 3 year survival of patients with white race and other race were 56% vs. 45%, p=0.050; 3 year OS for patients with T1-2 and T3-4 stage were 60.8% vs. 52.4%, p = 0.198. For patients with N0, N1, N2, and N3 stage, 3-year OS were 87.3%, 54.3%, 37.1%, and 0%, p < 0.001. Primary site of the tumor was not the prognostic factors. Nomograms were developed for the predicted OS with age, sex, ethnicity, T stage, and N stage. The calibration curve for probabilities showed relatively good agreement between prediction by nomogram and actual observation. The C-index of the nomograms for predicting for predicting OS is 0.63. The risk of having one of the indications of adjuvant radiation therapy increased with increases in predictors except for clinical T stage. Using clinical information, we produced nomograms, which may relatively accurately predict the probabilities of overall survival for patients with esophageal squamous cancer after chemoradiation therapy followed by surgery. This nomogram may help individualize initial treatment options.

An esophagectomy surgical Apgar score-based nomogram—a risk-based postoperative triage system: a phase II randomised trial

A neotype nomogram based on accessible clinical indicators to predict the overall survival of esophageal cancer patients underwent radical resection

Clinical Nomogram for Predicting Survival of Esophageal Cancer Patients after Esophagectomy

The value of esophagectomy surgical apgar score (eSAS) in predicting the risk of major morbidity after open esophagectomy.

Nomogram to Predict Intensive Care Following Gastrectomy for Gastric Cancer: A Useful Clinical Tool to Guide the Decision-Making of Intensive Care Unit Admission

Development of a prognostic nomogram and risk stratification system for upper thoracic esophageal squamous cell carcinoma

Risk prediction nomogram for major morbidity related to primary resection for esophageal squamous cancer

Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data

Development and validation of a new clinical staging system to predict survival for esophageal squamous cell carcinoma patients: Application of the nomogram.

A novel nomogram with preferable capability in predicting the overall survival of patients after radical esophageal cancer resection based on accessible clinical indicators: A comparison with AJCC staging

Survival risk stratification based on prognosis nomogram to identify patients with esophageal squamous cell carcinoma who may benefit from postoperative adjuvant therapy

Prognostic prediction model for patients with pathological T1N0 stage esophageal squamous cell carcinoma undergone esophagectomy

Nomogram based on pretreatment hepatic and renal function indicators for survival prediction of locally advanced esophageal squamous cell carcinoma with treatment of neoadjuvant chemoradiotherapy plus surgery

Nomogram constructed by immunological and inflammatory indicators for predicting prognosis of patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy plus surgery

Development and Validation of a Clinical Prognostic Nomogram for Esophageal Adenocarcinoma Patients

Development and validation of a prognostic nomogram for esophageal cancer patients based on SEER Asian population

A Preoperative Nomogram for Tumor Regression Grade Following Induction Chemotherapy for Esophageal Squamous Cell Carcinoma.

Construction of a novel nomogram for predicting overall survival in patients with Siewert type II AEG based on LODDS: a study based on the seer database and external validation

Development of nomogram for predicting major complications in patients with esophageal cancer in the early postoperative period

Surgical Apgar score is strongly associated with postoperative ICU admission

A Reliable Nomogram is Identified to Predict the Overall Survival for Patients with Esophageal Squamous Cancer after Chemoradiation Therapy Followed by Surgery